Evidence map›Paper›PMID 21732626›Full record

ArticleJournal of medicinal chemistry2011

Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for σ1 receptors.

Wei Wang, Jinquan Cui, Xiaoxia Lu, Prashanth K Padakanti, Jinbin Xu, Stanley M Parsons, Robert R Luedtke, Nigam P Rath, Zhude Tu

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Evaluation of [Molecular imaging and biology · 2022
    Article
  7. Article
  8. Kinetic modeling of [Journal of neurochemistry · 2018
    Article
  9. Article
  10. Chiral resolution of serial potent and selective σBioorganic & medicinal chemistry · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Radiosynthesis andMedChemComm · 2014
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Wei WangDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Jinquan Cui
Xiaoxia Lu
Prashanth K Padakanti
Jinbin Xu
Stanley M Parsons
Robert R Luedtke
Nigam P Rath
Zhude Tu
Washington University in St. Louis · USUniversity of California, Santa Barbara · USUniversity of Missouri–St. Louis · USUniversity of North Texas Health Science Center · US

Funding

PET PROBES FOR IMAGING THE VESICULAR ACETYLCHOLINE TRANSPORTERR01NS075527 · NINDS · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2011 to 2021
$4.9M
DEVELOPING PET AGENTS FOR IMAGING PHOSPHODIESTERASE 10A (PDE10A)R33MH092797 · NIMH · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2013 to 2015
$1.5M
Dopamine D2 Selective Imaging AgentsR33MH081281 · NIMH · WASHINGTON UNIVERSITY · PI MACH, ROBERT H · 2009 to 2011
$1.2M
DEVELOPMENT OF VESICULAR ACETYLCHOLINE TRANSPORTER IMAGING AGENTS FOR PETR21NS061025 · NINDS · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2009 to 2010
$628k
DEVELOPING PET AGENTS FOR IMAGING PHOSPHODIESTERASE 10A (PDE10A)R21MH092797 · NIMH · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2011 to 2012
$530k
Dopamine D2 Selective Imaging AgentsR21MH081281 · NIMH · WASHINGTON UNIVERSITY · PI MACH, ROBERT H · 2007 to 2008
$417k
NIMH NIH HHS MH092-797-01NIMH NIH HHS R21 MH081281NIMH NIH HHS R21 MH092797NIMH NIH HHS R33 MH081281NIMH NIH HHS R33 MH092797NINDS NIH HHS R01 NS075527NINDS NIH HHS R21 NS061025
6 · The paper itself

Abstract

To identify the ligands for σ(1) receptors that are potent and selective, analogues of prezamicol and trozamicol scaffolds of carbonyl-containing vesicular acetylcholine transporter (VAChT) inhibitors were explored. Of the 23 analogues synthesized and tested, 5 displayed very high affinity for σ(1) (K(i) = 0.48-4.05 nM) and high selectivity for σ(1) relative to σ(2) receptors (σ(1)/σ(2) selectivity of >749-fold). Four of the five compounds (14a, 14b, 14c, and 14e) showed very low affinity for VAChT (K(i) > 290 nM), and the fifth compound (14g) showed moderate affinity for VAChT (K(i) = 44.2 nM). The compound [1'-(4-fluorobenzyl)-3'-hydroxy[1,4']bipiperidinyl-4-yl]-(4-fluorophenyl)methanone (14a) displayed very high affinity and selectivity for σ(1) receptor (K(i) = 0.48 nM, σ(1)/σ(2) > 3600). All four of these most promising compounds (14a, 14b, 14c, and 14e) can be radiosynthesized with fluorine-18 or carbon-11, which will allow further evaluation of their properties as PET probes for imaging σ(1) receptor in vivo.

Indexed as

AnimalsGuinea PigsHumansPC12 CellsPiperidinesRatsReceptors, sigmaStructure-Activity RelationshipVesicular Acetylcholine Transport ProteinsPiperidinesReceptors, sigmaVesicular Acetylcholine Transport Proteins

Identifiers

PMID21732626
PMCPMC3150604
OpenAlexW2318096101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.